Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer

#2021
#Cancers

PMU Autor*innen
Christian Reinhard Mayr, Tobias Kiesslich, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Tarkan Jäger, Bettina Neumayer, Eckhard Klieser, Daniel Neureiter

Alle Autor*innen
Christian Reinhard Mayr, Tobias Kiesslich, Sara Erber, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Tarkan Jäger, Bettina Neumayer, Paul Winkelmann, Eckhard Klieser, Daniel Neureiter

Fachzeitschrift
Cancers

Kurzfassung

Keywords

EXPRESSION, STEM-CELLS, GROWTH, PROLIFERATION, CARCINOMA-CELL-LINE, ESTABLISHMENT, CHOLANGIOCARCINOMA, HISTONE DEACETYLASE INHIBITOR, TRICHOSTATIN, DEPSIPEPTIDE